Page:United States Statutes at Large Volume 124.djvu/333

 124 STAT. 307 PUBLIC LAW 111–148—MAR. 23, 2010 ‘‘(II) DRUG DESCRIBED.—For purposes of sub- clause (I), a single source drug or an innovator multiple source drug described in this subclause is any of the following drugs: ‘‘(aa) A clotting factor for which a separate furnishing payment is made under section 1842(o)(5) and which is included on a list of such factors specified and updated regularly by the Secretary. ‘‘(bb) A drug approved by the Food and Drug Administration exclusively for pediatric indications.’’. (2) RECAPTURE OF TOTAL SAVINGS DUE TO INCREASE.—Sec- tion 1927(b)(1) of such Act (42 U.S.C. 1396r–8(b)(1)) is amended by adding at the end the following new subparagraph: ‘‘(C) SPECIAL RULE FOR INCREASED MINIMUM REBATE PERCENTAGE.— ‘‘(i) IN GENERAL.—In addition to the amounts applied as a reduction under subparagraph (B), for rebate periods beginning on or after January 1, 2010, during a fiscal year, the Secretary shall reduce pay- ments to a State under section 1903(a) in the manner specified in clause (ii), in an amount equal to the product of— ‘‘(I) 100 percent minus the Federal medical assistance percentage applicable to the rebate period for the State; and ‘‘(II) the amounts received by the State under such subparagraph that are attributable (as esti- mated by the Secretary based on utilization and other data) to the increase in the minimum rebate percentage effected by the amendments made by subsections (a)(1), (b), and (d) of section 2501 of the Patient Protection and Affordable Care Act, taking into account the additional drugs included under the amendments made by subsection (c) of section 2501 of such Act. The Secretary shall adjust such payment reduction for a calendar quarter to the extent the Secretary determines, based upon subsequent utilization and other data, that the reduction for such quarter was greater or less than the amount of payment reduction that should have been made. ‘‘(ii) MANNER OF PAYMENT REDUCTION.—The amount of the payment reduction under clause (i) for a State for a quarter shall be deemed an overpayment to the State under this title to be disallowed against the State’s regular quarterly draw for all Medicaid spending under section 1903(d)(2). Such a disallowance is not subject to a reconsideration under section 1116(d).’’. (b) INCREASE IN REBATE FOR OTHER DRUGS.—Section 1927(c)(3)(B) of such Act (42 U.S.C. 1396r–8(c)(3)(B)) is amended— (1) in clause (i), by striking ‘‘and’’ at the end; (2) in clause (ii)— (A) by inserting ‘‘and before January 1, 2010,’’ after ‘‘December 31, 1993,’’; and Determination. Time period.